RecruitingNot applicableNCT07330271
PTC-Guided Therapy for Peritoneal Mesothelioma
Studying Malignant peritoneal mesothelioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Intervention
- PTC guided individualized treatment(drug)
- Enrollment
- 347 target
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2025 – 2031
Study locations (1)
- Tsinghua University affiliated Beijing Tsinghua Changgung Hospital, Beijing, China
Collaborators
Beijing Shijitan Hospital, Capital Medical University · Cangzhou Central Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07330271 on ClinicalTrials.govOther trials for Malignant peritoneal mesothelioma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06543069Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeMCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGNCT06581549Immune Microenvironment and Gene Expression Profiling in MesotheliomaIstituto Oncologico Veneto IRCCS
- RECRUITINGPHASE2NCT06057935A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaMemorial Sloan Kettering Cancer Center